Sol J. Barer's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 21,739 Restricted Share Units done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- Pharmaceutical Indus... | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 21,739 | 21,739 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 17,158 | 426,272 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 17,158 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 37,598 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 37,598 | 409,114 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 17,158 | 17,158 | - | - | Restricted Share Units | |
| Neximmune Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 155,900 | 155,900 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 155,900 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 19,113 | 19,113 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 19,113 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 30 Mar 2023 | 400,000 | 2,217,814 | - | 0.4 | 164,120 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 16 Nov 2022 | 125,000 | 1,742,814 | - | 0.5 | 60,300 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 16 Nov 2022 | 75,000 | 1,817,814 | - | 0.5 | 35,918 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 31 May 2022 | 40,000 | 1,597,094 | - | 2.4 | 94,160 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 31 May 2022 | 39,280 | 1,557,094 | - | 2.2 | 85,894 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 31 May 2022 | 20,720 | 1,617,814 | - | 2.2 | 46,100 | Common Stock |
| ContraFect Corp | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 42,000 | 42,000 | - | - | Options (Right to Buy) | |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 23 Mar 2022 | 10,000 | 1,517,814 | - | 2.7 | 26,653 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.41 per share. | 22 Mar 2022 | 30,000 | 1,507,814 | - | 2.4 | 72,300 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 21 Mar 2022 | 30,000 | 1,477,814 | - | 2.1 | 64,080 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 18 Mar 2022 | 30,000 | 1,447,814 | - | 2.1 | 63,210 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 21 Dec 2021 | 50,000 | 1,417,814 | - | 5.2 | 258,500 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 50,000 | 155,900 | - | - | Stock Option (right to buy) | |
| Avalo Therapeutics Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| ContraFect Corp | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 25,000 | 25,000 | - | - | Options (Right to Buy) | |
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 894,036 | 894,036 | - | - | Common Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 894,036 | 0 | - | - | Series A Preferred Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 800,182 | 0 | - | - | Series A Preferred Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 800,182 | 1,367,814 | - | - | Common Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 337,365 | 1,478,013 | - | - | Common Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 217,570 | 0 | - | - | Series A Preferred Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 217,570 | 346,577 | - | - | Common Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 164,408 | 0 | - | - | Series A2 Preferred Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 164,408 | 1,058,444 | - | - | Common Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 82,204 | 0 | - | - | Series A3 Preferred Stock | ||
| Neximmune Inc | Sol J. Barer | Director | 17 Feb 2021 | 82,204 | 1,140,648 | - | - | Common Stock | ||
| Neximmune Inc | Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Feb 2021 | 60,000 | 1,538,013 | - | 17 | 1,020,000 | Common Stock |
| Neximmune Inc | Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 19,113 | 225,013 | - | - | Stock Option (right to buy) |